...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Re: Notice anything different about #11

fouremm - My observation was that there was no partner for that trial. MSK is a clinic as far as I know. I have never heard of a clinic participating as a trial parter. If they are partnering it would only mean there could be yet another excuse for the company to not keep investors updated in a timely fashion.

tada 

Share
New Message
Please login to post a reply